In Vitro Assessment of a MAF‐1A‐Derived Peptide Against Candida parapsilosis : Antifungal Potency, Trypsin Stability, and Hemolytic Safety
Journal of Peptide Science · 2026
DOI: 10.1002/psc.70127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Peptide Science, 2026. Verfasst von Mei Tao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou University Medical College, Guiyang, Guizhou Province, China. Hauptthemen laut MEDLINE: Antifungal Agents, Trypsin, Candida parapsilosis, Peptides. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Health Commission Joint Fund for High-Quality Medical Research Development.
Abstract (Originalsprache)
Candida parapsilosis ( C. parapsilosis ) has caused more infections in recent years, and resistance to conventional antifungal agents is also rising. This study evaluated the antifungal potential of a newly designed MAF‐1A‐derived peptide against C. parapsilosis . Four derivatives were chemically synthesized and structurally characterized. Our hybrid method included the use of computational tools for hydrophobic optimization, amphipathic α‐helix stabilization, and peptide‐membrane interaction prediction together with experimental validations. We synthesized four designed derivatives (8KGF7, 9GIF6, 10KLF6, and 10GIF6) by Fmoc‐based solid‐phase chemistry. Its antifungal activity against C. parapsilosis was assessed using the broth microdilution assay. Trypsin stability was evaluated by incubating 10KLF6 with trypsin followed by measurement of residual antifungal activity. Hemolytic safety was assessed using human red blood cells via hemolytic activity assays. The results demonstrated that 10KLF6 exhibited up to 15‐fold higher antifungal activity against C. parapsilosis compared to MAF‐1A. Additionally, 10KLF6 retained more than 20% of its antifungal activity after 100 min of trypsin digestion and showed low hemolytic toxicity. Collectively, 10KLF6 possesses potent antifungal activity as well as favorable stability and safety profiles against C. parapsilosis , which supports its further exploration as a promising candidate for the development of potent and stable antifungal peptide agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guizhou University Medical College, Guiyang, Guizhou Province, China.
- Department of Cardiovascular Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China.
- The Key Laboratory of Myocardial Remodeling Research, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China.
- Department of Clinical Laboratory, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
- College of Laboratory Medicine, Guizhou Medical University, Guiyang, Guizhou Province, China.
- The First Clinical Institute of, Zunyi Medical University, Zunyi, Guizhou Province, China.
ORCID-Profile: Mei Tao, Runze Huang, Fangfang Hu, Xuejun Zhao, Nan Cen, Cenying Liu, Wei Li, Zhenhua Luo
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Health Commission Joint Fund for High-Quality Medical Research Development
Zitieren
APA
Tao, M., Huang, R., Hu, F., Zhao, X., Cen, N., Liu, C., Li, W., & Luo, Z. (2026). In Vitro Assessment of a MAF‐1A‐Derived Peptide Against Candida parapsilosis : Antifungal Potency, Trypsin Stability, and Hemolytic Safety. Journal of Peptide Science. https://doi.org/10.1002/psc.70127
Vancouver
Tao M, Huang R, Hu F, Zhao X, Cen N, Liu C, et al. In Vitro Assessment of a MAF‐1A‐Derived Peptide Against Candida parapsilosis : Antifungal Potency, Trypsin Stability, and Hemolytic Safety. Journal of Peptide Science. 2026. doi:10.1002/psc.70127
BibTeX
@article{Tao2026,
author = {Tao, Mei and Huang, Runze and Hu, Fangfang and Zhao, Xuejun and Cen, Nan and Liu, Cenying and Li, Wei and Luo, Zhenhua},
title = {In Vitro Assessment of a MAF‐1A‐Derived Peptide Against Candida parapsilosis : Antifungal Potency, Trypsin Stability, and Hemolytic Safety},
journal = {Journal of Peptide Science},
year = {2026},
doi = {10.1002/psc.70127}
}
EUVIMED